Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review

L Lakin, BE Davis, CC Binns, KM Currie… - Neurology and therapy, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …

Multiple sclerosis management during the COVID-19 pandemic

BP Moss, KR Mahajan, RA Bermel… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: People with multiple sclerosis (MS) may be at higher risk for complications from
the 2019 coronavirus (COVID-19) pandemic due to use of immunomodulatory disease …

Mobile health (mHealth) usage, barriers, and technological considerations in persons with multiple sclerosis: a literature review

ES Gromisch, AP Turner, JK Haselkorn, AC Lo… - JAMIA …, 2021 - academic.oup.com
Objectives Persons with multiple sclerosis (MS) can face a number of potential healthcare-
related barriers, for which mobile health (mHealth) technology can be potentially beneficial …

Depression in multiple sclerosis across the adult lifespan

CK Chan, F Tian… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Objectives: The objective of this study is to examine the burden of depressive symptoms
across the adult age span in people with multiple sclerosis (MS) and test if the relationship …

The integration of clinical data in the assessment of multiple sclerosis–A review

S Ostellino, A Benso, G Politano - Computer Methods and Programs in …, 2022 - Elsevier
Abstract Background and Objectives: Multiple Sclerosis (MS) is a neurological disease
associated with various and heterogeneous clinical characteristics. Given its complex nature …

[HTML][HTML] Multiple sclerosis performance test (MSPT): normative study of 428 healthy participants ages 18 to 89

SM Rao, M Sokolowski, LB Strober, JB Miller… - Multiple Sclerosis and …, 2022 - Elsevier
Abstract Background The Multiple Sclerosis Performance Test (MSPT) is a self-
administered, iPad®-based, computerized system for quantifying neuroperformance …

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment

MF Raghib, E Bernitsas - Biomedicines, 2023 - mdpi.com
Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central
nervous system (CNS). Microbes, including bacteria and certain viruses, particularly Epstein …

Can we improve the monitoring of people with multiple sclerosis using simple tools, data sharing, and patient engagement?

K Allen-Philbey, R Middleton, K Tuite-Dalton… - Frontiers in …, 2020 - frontiersin.org
Technological innovation is transforming traditional clinical practice, enabling people with
multiple sclerosis (pwMS) to contribute health care outcome data remotely between clinic …

Associations between cognitive impairment and neuroimaging in patients with multiple sclerosis

O Wilcox, M Amin, L Hancock… - Archives of Clinical …, 2024 - academic.oup.com
Objective Multiple sclerosis (MS) is a debilitating inflammatory and neurodegenerative
disease which commonly involves cognitive dysfunction. Magnetic resonance imaging (MRI) …

[HTML][HTML] Duration of rehabilitation therapy to achieve a minimal clinically important difference in mobility, walking endurance and patient-reported physical health: an …

K Nicoline, K Jan, S Bachmann - Journal of Rehabilitation …, 2023 - ncbi.nlm.nih.gov
Objective To compare the duration of exercise therapy needed to achieve a minimal
clinically important difference in mobility, walking endurance and patient-reported global …